Dudnyk heads west to serve California biotech firms

Share this article:

Indie medical advertising agency Dudnyk opened a southern California office, citing unmet need among the thousand or so biotech firms in the area.

The Philadelphia-based agency set up shop in Carlsbad, CA,  between San Diego and Los Angeles, and named Scott Greisler to lead the firm as SVP, general manager.

“Commercial development teams in biotech companies are facing increasing pressure,” Greis­ler said. “Because companies are leaner than ever, they often lack the full power of pharma marketing departments in terms of planning, strategy, or brand development. By setting up shop in close proximity to the companies who need us most, Dudnyk will be in the best position to offer expertise and work in partnership with biotech companies to bring their revolutionary brands to successful commercial launch.”

Greisler is moving from the agency's Horsham, PA, headquarters, where he was SVP, director of client services.

The agency has positioned itself as the go-to shop for biotech branding, having launched seven commercial products in five years for biotechs. The firm has several clients in California, but hopes its move will help build out its West Coast presence.

“This move extends our physical footprint, but even more, we are excited about the opportunity to have a positive impact on the southern California biotech community,” said president Frank X. Powers.  “This region is poised to be one of the hottest growth areas in the country for biotech for the next five years.”

In other Dudnyk news, the company named Therese Heimbold, formerly of ViroPharma, director of brand strategy and appointed three creative directors: John Kemble and Tara Walther (art) and Laurie Bartolomeo (copy).
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.